静脉注射免疫球蛋白治疗的安全性。
Safety of intravenous immunoglobulin treatment.
作者信息
Atrah H I, Crawford R J, Dow B C, Mitchell R
出版信息
J Clin Pathol. 1985 Oct;38(10):1192-3. doi: 10.1136/jcp.38.10.1192.
Abstract
In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin products can apparently transmit non-A, non-B hepatitis.
摘要
在一项针对16例患者的前瞻性临床和生化研究中，这些患者接受了高剂量经pH 4条件下轻度胃蛋白酶处理而改良用于静脉注射的免疫球蛋白产品治疗，未发现肝炎迹象。这与最近有关静脉注射免疫球蛋白产品显然可传播非甲非乙型肝炎的报道形成对比。
相似文献
1
Safety of intravenous immunoglobulin treatment.静脉注射免疫球蛋白治疗的安全性。
J Clin Pathol. 1985 Oct;38(10):1192-3. doi: 10.1136/jcp.38.10.1192.
2
[Cyclic thrombocytopenia treated by high-dose intravenous immunoglobulin with a favorable response].[大剂量静脉注射免疫球蛋白治疗循环性血小板减少症并取得良好疗效]
Rinsho Ketsueki. 1988 May;29(5):705-10.
3
Use of intravenous normal immunoglobulin in high doses as a possible safer alternative to oral steroids in managing HIV-associated immune thrombocytopenic purpura.大剂量静脉注射正常免疫球蛋白作为治疗HIV相关免疫性血小板减少性紫癜时口服类固醇可能更安全的替代方案。
J Infect. 1986 Nov;13(3):312-3. doi: 10.1016/s0163-4453(86)91817-7.
4
Does Cohn-fractionated Rh immune globulin transmit viral hepatitis?科恩分级的Rh免疫球蛋白会传播病毒性肝炎吗？
Transfusion. 1985 Jan-Feb;25(1):15-7. doi: 10.1046/j.1537-2995.1985.25185116492.x.
5
[Indications for high-dose immunoglobulin therapy in idiopathic thrombocytopenic purpura and its evaluation].
Rinsho Ketsueki. 1986 Sep;27(9):1712-20.
6
Use of intravenous immunoglobulin in severe refractory idiopathic immune thrombocytopenia.静脉注射免疫球蛋白在重度难治性特发性免疫性血小板减少症中的应用
J R Soc Med. 1987 Oct;80(10):652-4. doi: 10.1177/014107688708001021.
7
Applications of intravenous immunoglobulin.静脉注射免疫球蛋白的应用。
Malays J Pathol. 1990 Jun;12(1):1-10.
8
A clinical study of intravenous immunoglobulin therapy for childhood idiopathic thrombocytopenic purpura.
Taiwan Yi Xue Hui Za Zhi. 1989 Mar;88(3):244-7.
9
[New indications for intravenous immunoglobulins].[静脉注射免疫球蛋白的新适应症]
Rev Prat. 1990 May 21;40(15):1393-5.
10
[Treatment of idiopathic thrombopenic purpura with immunoglobulins].[用免疫球蛋白治疗特发性血小板减少性紫癜]
Presse Med. 1983 Nov 17;12(41):2608-11.
引用本文的文献
1
Use of intravenous immunoglobulin in severe refractory idiopathic immune thrombocytopenia.静脉注射免疫球蛋白在重度难治性特发性免疫性血小板减少症中的应用
J R Soc Med. 1987 Oct;80(10):652-4. doi: 10.1177/014107688708001021.
本文引用的文献
1
Non-A, non-B hepatitis markers in the west of Scotland.
Med Lab Sci. 1981 Oct;38(4):359-63.
2
Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.在治疗不频繁的患者中，输注凝血因子 VIII 后发生的非甲非乙型肝炎。
Br Med J (Clin Res Ed). 1983 Dec 10;287(6407):1754-7. doi: 10.1136/bmj.287.6407.1754.
3
The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.静脉注射免疫球蛋白在免疫血液学疾病治疗中的应用及作用机制。
Br J Haematol. 1984 Jan;56(1):1-7. doi: 10.1111/j.1365-2141.1984.tb01266.x.
4
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.静脉注射免疫球蛋白后无丙种球蛋白血症患者发生的非甲非乙型肝炎。
Lancet. 1984 Nov 10;2(8411):1062-4. doi: 10.1016/s0140-6736(84)91506-x.
5
Non-A, non-B hepatitis from intravenous immunoglobulin.静脉注射免疫球蛋白所致的非甲非乙型肝炎
Lancet. 1983 Nov 19;2(8360):1198-9. doi: 10.1016/s0140-6736(83)91250-3.
6
Non-A, non-B hepatitis from intravenous immunoglobulin.静脉注射免疫球蛋白所致的非甲非乙型肝炎
Lancet. 1983 Oct 22;2(8356):974-5. doi: 10.1016/s0140-6736(83)90496-8.
7
A West African epilepsy focus.一个西非癫痫病灶。
Lancet. 1983 Feb 12;1(8320):358. doi: 10.1016/s0140-6736(83)91663-x.
8
Non-A, non-B hepatitis and intravenous immunoglobulin.非甲非乙型肝炎与静脉注射免疫球蛋白
Lancet. 1985 Feb 16;1(8425):404-5.
Zotero 插件